Description

FINDOXIME-CV Tablets contain a combination of Cefpodoxime 200 mg and Potassium Clavulanate 125 mg, formulated to provide broad-spectrum antibacterial coverage against a wide range of susceptible bacterial infections. Cefpodoxime, a third-generation cephalosporin antibiotic, inhibits bacterial cell wall synthesis, while Potassium Clavulanate acts as a beta-lactamase inhibitor, enhancing the effectiveness of Cefpodoxime against resistant organisms.

This combination is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and other bacterial conditions caused by beta-lactamase–producing bacteria. FINDOXIME-CV offers improved antibacterial efficacy and reliable infection control when used as directed.

Key Highlights:

• Contains Cefpodoxime 200 mg + Potassium Clavulanate 125 mg

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Used in respiratory, ENT, UTI, and skin infections

• Enhances treatment success and bacterial eradication

• Well-suited for moderate to severe infections

• To be used under medical supervision

Dosage and duration should be followed exactly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula than please contact us.